Aviation Medication Transparency Act of 2025

Increased Transparency: The bill requires the Administrator to publish and maintain a list of medications and treatments on a publicly available website (Section 2(a)). This provides clarity on what can be safely prescribed to an airman.

Improved Accessibility for Airmen: The list must be drafted in a user-friendly and accessible manner and provided to airmen when they first seek a license and medical certification (Section 2(b)(3)).

Clearer Expectations for Medication Use: The list must indicate the average period of time an airman might need limited or no duties to stabilize on an approved medication (Section 2(b)(4)).

Direct Communication for Medical Professionals: The requirement to include a mechanism for doctors or medical providers to contact the FAA regarding the list allows for direct clarification of medical questions (Section 2(b)(6)).

Collaborative Drafting: The list is drafted in consultation with various stakeholders, including the Aeromedical Innovation and Modernization Working Group and certified bargaining representatives for air traffic controllers and airline pilots (Section 2(b)(1)).